The Oncosearch | Oncotarget

Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model Research Paper

Dudley W. Lamming, Nicole E. Cummings, Antonella L. Rastelli, Feng Gao, Edda Cava, Beatrice Bertozzi, Francesco Spelta, Roberto Pili, Luigi Fontana

Published Sep 3, 2015 · Vol. 6, No. 31 · pp. 31233-31240

Triple-layer dissection of the lung adenocarcinoma transcriptome â€“ regulation at the gene, transcript, and exon levels Research Paper

Min-Kung Hsu, I-Ching Wu, Ching-Chia Cheng, Jen-Liang Su, Chang-Huain Hsieh, Yeong-Shin Lin, Feng-Chi Chen

Published Sep 2, 2015 · Vol. 6, No. 30 · pp. 28755-28773

Quaking and miR-155 interactions in inflammation and leukemogenesis Priority Research Paper

Esmerina Tili, Marcela Chiabai, Dario Palmieri, Melissa Brown, Ri Cui, Cecilia Fernandes, Tim Richmond, Taewan Kim, Tyler Sheetz, Hui-Lung Sun, Alessandro Lagana, Dario Veneziano, Stefano Volinia, Laura Rassenti, Thomas Kipps, Hamdy Awad, Jean-Jacques Michaille, Carlo M. Croce

Published Aug 24, 2015 · Vol. 6, No. 28 · pp. 24599-24610

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients Research Paper

Bruno Vincenzi, Chiara Cremolini, Andrea Sartore-Bianchi, Antonio Russo, Francesco Mannavola, Giuseppe Perrone, Francesco Pantano, Fotios Loupakis, Daniele Rossini, Elena Ongaro, Erica Bonazzina, Emanuela Dellâ€™Aquila, Marco Imperatori, Alice Zoccoli, Giuseppe Bronte, Giovanna De Maglio, Gabriella Fontanini, Clara Natoli, Alfredo Falcone, Daniele Santini, Andrea Onetti-Muda, Salvatore Siena, Giuseppe Tonini, Giuseppe Aprile

Published Aug 19, 2015 · Vol. 6, No. 31 · pp. 31604-31612

Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors Research Paper

Daniela Damiani, Mario Tiribelli, Donatella Raspadori, Santina Sirianni, Alessia Meneghel, Margherita Cavalllin, Angela Michelutti, Eleonora Toffoletti, Antonella Geromin, Erica Simeone, Monica Bocchia, Renato Fanin

Published Aug 18, 2015 · Vol. 6, No. 30 · pp. 30212-30221

RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb Research Paper

Jinhua Wang, Wei Hua, Sharon K. Huang, Kun Fan, Ling Takeshima, Ying Mao, Dave S.B. Hoon

Published Aug 17, 2015 · Vol. 6, No. 30 · pp. 30165-30177

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death Research Paper

Daniela Catanzaro, Edoardo Gaude, Genny Orso, Carla Giordano, Giulia Guzzo, Andrea Rasola, Eugenio Ragazzi, Laura Caparrotta, Christian Frezza, Monica Montopoli

Published Aug 17, 2015 · Vol. 6, No. 30 · pp. 30102-30114

Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-ÎºB in colon cancer Research Paper

Lakshmi Prabhu, Rasika Mundade, Benlian Wang, Han Wei, Antja-Voy Hartley, Matthew Martin, Kyle McElyea, Constance J. Temm, George Sandusky, Yunlong Liu, Tao Lu

Published Aug 8, 2015 · Vol. 6, No. 30 · pp. 29396-29412

A bacterial toxin that cleaves Ras oncoprotein Editorial

Marco Biancucci, Karla J.F. Satchell

Published Aug 7, 2015 · Vol. 6, No. 22 · pp. 18742-18743

Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity Research Paper

Anton Danilov, Mikhail Shaposhnikov, Oksana Shevchenko, Nadezhda Zemskaya, Alex Zhavoronkov, Alexey Moskalev

Published Aug 7, 2015 · Vol. 6, No. 23 · pp. 19428-19444

Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells Research Paper

Nourdine Hamdane, Chelsea Herdman, Jean-Clement Mars, Victor Stefanovsky, Michel G. Tremblay, Tom Moss

Published Aug 7, 2015 · Vol. 6, No. 29 · pp. 27519-27536

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status Research Paper

Luigi Formisano, Valentina Dâ€™Amato, Alberto Servetto, Simona Brillante, Lucia Raimondo, Concetta Di Mauro, Roberta Marciano, Roberta Clara Orsini, Sandro Cosconati, Antonio Randazzo, Sarah J. Parsons, Nunzia Montuori, Bianca Maria Veneziani, Sabino De Placido, Roberta Rosa, Roberto Bianco

Published Aug 3, 2015 · Vol. 6, No. 28 · pp. 26090-26103

Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Review

Markus Morkel, Pamela Riemer, Hendrik BlÃ¤ker, Christine Sers

Published Jul 30, 2015 · Vol. 6, No. 25 · pp. 20785-20800

⁸⁹Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers

Catherina Willemien Menke-van der Houven, Elske C Gootjes, Marc C Huisman, Danielle J Vugts, Chantal Roth, Anne Marije Luik, Emma R Mulder, Robert C Schuit, Ronald Boellaard, Otto S Hoekstra, Guus AMS van Dongen, Henk MW Verheul

Published Jul 23, 2015 · Vol. 6, No. 30 · pp. 30384-30393

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and EÂµ-MYC driven B-cell lymphoma Research Paper

Mike I. Walton, Paul D. Eve, Angela Hayes, Alan T. Henley, Melanie R. Valenti, Alexis K. De Haven Brandon, Gary Box, Kathy J. Boxall, Matthew Tall, Karen Swales, Thomas P. Matthews, Tatiana McHardy, Michael Lainchbury, James Osborne, Jill E. Hunter, Neil D. Perkins, G. Wynne Aherne, John C. Reader, Florence I. Raynaud, Suzanne A. Eccles, Ian Collins, Michelle D. Garrett

Published Jul 22, 2015 · Vol. 7, No. 3 · pp. 2329-2342

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Review

Giuseppe Bronte, Nicola Silvestris, Marta Castiglia, Antonio Galvano, Francesco Passiglia, Giovanni Sortino, Giuseppe Cicero, Christian Rolfo, Marc Peeters, Viviana Bazan, Daniele Fanale, Antonio Giordano, Antonio Russo

Published Jul 22, 2015 · Vol. 6, No. 28 · pp. 24780-24796

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma Priority Research Paper

Arindam P. Ghosh, Christopher B. Marshall, Tatjana Coric, Eun-hee Shim, Richard Kirkman, Mary E. Ballestas, Mitsuhiko Ikura, Mary-Ann Bjornsti, Sunil Sudarshan

Published Jul 22, 2015 · Vol. 6, No. 20 · pp. 17895-17910

The 26S proteasome is a multifaceted target for anti-cancer therapies Review

Tatyana A. Grigoreva, Vyacheslav G. Tribulovich, Alexander V. Garabadzhiu, Gerry Melino, Nickolai A. Barlev

Published Jul 20, 2015 · Vol. 6, No. 28 · pp. 24733-24749

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Research Paper

Daniel Oâ€™Neill, Dominic Jones, Mark Wade, James Grey, Sirintra Nakjang, Wenrui Guo, David Cork, Barry R. Davies, Steve R. Wedge, Craig N. Robson, Luke Gaughan

Published Jul 20, 2015 · Vol. 6, No. 28 · pp. 26029-26040

Keywords: Prostate cancer, Androgen receptor, Mutation, Anti-androgen-resistance, SGK1

Cisplatin inhibits MEK1/2 Research Paper

Tetsu Yamamoto, Igor F. Tsigelny, Andreas W. GÃ¶tz, Stephen B. Howell

Published Jun 20, 2015 · Vol. 6, No. 27 · pp. 23510-23522

Keywords: MEK1, RAS, ERK, copper, cisplatin

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model Research Paper

Triple-layer dissection of the lung adenocarcinoma transcriptome â€“ regulation at the gene, transcript, and exon levels Research Paper

Quaking and miR-155 interactions in inflammation and leukemogenesis Priority Research Paper

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients Research Paper

Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors Research Paper

RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb Research Paper

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death Research Paper

Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-ÎºB in colon cancer Research Paper

A bacterial toxin that cleaves Ras oncoprotein Editorial

Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity Research Paper

Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells Research Paper

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status Research Paper

Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Review

⁸⁹Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and EÂµ-MYC driven B-cell lymphoma Research Paper

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Review

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma Priority Research Paper

The 26S proteasome is a multifaceted target for anti-cancer therapies Review

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Research Paper

Cisplatin inhibits MEK1/2 Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model Research Paper

Triple-layer dissection of the lung adenocarcinoma transcriptome â€“ regulation at the gene, transcript, and exon levels Research Paper

Quaking and miR-155 interactions in inflammation and leukemogenesis Priority Research Paper

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients Research Paper

Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors Research Paper

RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb Research Paper

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death Research Paper

Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-ÎºB in colon cancer Research Paper

A bacterial toxin that cleaves Ras oncoprotein Editorial

Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity Research Paper

Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells Research Paper

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status Research Paper

Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Review

89Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and EÂµ-MYC driven B-cell lymphoma Research Paper

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Review

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma Priority Research Paper

The 26S proteasome is a multifaceted target for anti-cancer therapies Review

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy Research Paper

Cisplatin inhibits MEK1/2 Research Paper

⁸⁹Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers